Hosam Elbanna
Al Mansurah, Dakahlia Governorate, Egypt
NCT Number: NCT02638064
Assessment of surgiflo injection for treating pilonidal sinus disease
Looking for future studies?
Notify Me14 year–45 year
All sexes
Interventional
Not applicable
Al Mansurah, Dakahlia Governorate, Egypt
Evaluation of injection of Surgiflo as a sealent in treatment of pilonidal sinus, evaluation includes recurrence, infection, complications and patient satisfaction over 2 years of follow up
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients included in the study had simple midline PS with single or multiple tracts and no lateral extensions. Recurrent cases of PS after previous surgery were also included in the study
Exclusion criteria
We excluded from the study patients with severe scarring at the natal cleft due to previous surgery or infection and patients with signs of an acute abscess.
Curettage of sinus cavity then injection of surgiflo material
Time frame: 2 years
number of patients presenting with recurrent pilonidal sinus
Time frame: 2 years
number of patients presenting with complications after injection of surgiflo
Mansoura University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06721169
Pilonidal Sinus Disorder, Pilonidal Sinus Treatment
Mersin, Turkey (Türkiye)
View Trial DetailsNCT07370714
Cysts, Neoplasms
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07260643
Cysts, Neoplasms
View Trial Details